Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 12/2009

01.12.2009 | Article

Antimicrobial stewardship program directed at broad-spectrum intravenous antibiotics prescription in a tertiary hospital

verfasst von: V. C. C. Cheng, K. K. W. To, I. W. S. Li, B. S. F. Tang, J. F. W. Chan, S. Kwan, R. Mak, J. Tai, P. Ching, P. L. Ho, W. H. Seto

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 12/2009

Einloggen, um Zugang zu erhalten

Abstract

The antimicrobial stewardship program (ASP) is a major strategy to combat antimicrobial resistance and to limit its expenditure. We have improved on our existing ASP to implement a sustainable and cost-effective two-stage immediate concurrent feedback (ICF) model, in which the antimicrobial prescription is audited by two part-time infection control nurses at the first stage, followed by “physician ICF” at the second stage. In January 2005, an ASP focused on broad-spectrum intravenous antibiotics was implemented. All in-patients, except from the intensive care, bone marrow transplantation, liver transplantation, pediatric, and private units, being treated with broad-spectrum intravenous antibiotics were included. The compliance to ICF and “physician ICF”, antibiotics usage density measured by expenditure and defined daily doses (DDD) were recorded and analyzed before and after the ASP. The overall conformance rate to antibiotic prescription guidelines was 79.4%, while the conformance to ICF was 83.8%. Antibiotics consumption reduced from 73.06 (baseline, year 2004) to 64.01 (year 2007) per 1,000 patient bed-day-occupancy. Our model can be easily applied even in the clinical setting of limited resources.
Literatur
1.
Zurück zum Zitat Smith RD (1999) Antimicrobial resistance: the importance of developing long-term policy. Bull World Health Organ 77:862PubMed Smith RD (1999) Antimicrobial resistance: the importance of developing long-term policy. Bull World Health Organ 77:862PubMed
2.
Zurück zum Zitat Bell JM, Turnidge JD, SENTRY APAC (2002) High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program, 1998–1999. Antimicrob Agents Chemother 46:879–881CrossRefPubMed Bell JM, Turnidge JD, SENTRY APAC (2002) High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program, 1998–1999. Antimicrob Agents Chemother 46:879–881CrossRefPubMed
3.
Zurück zum Zitat Ho PL, Tse WS, Tsang KW, Kwok TK, Ng TK, Cheng VC, Chan RM (2001) Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study. Clin Infect Dis 32:701–707CrossRefPubMed Ho PL, Tse WS, Tsang KW, Kwok TK, Ng TK, Cheng VC, Chan RM (2001) Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study. Clin Infect Dis 32:701–707CrossRefPubMed
4.
Zurück zum Zitat Ho PL, Yung RW, Tsang DN, Que TL, Ho M, Seto WH, Ng TK, Yam WC, Ng WW (2001) Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother 48:659–665CrossRefPubMed Ho PL, Yung RW, Tsang DN, Que TL, Ho M, Seto WH, Ng TK, Yam WC, Ng WW (2001) Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother 48:659–665CrossRefPubMed
5.
Zurück zum Zitat Ho PL, Que TL, Chiu SS, Yung RW, Ng TK, Tsang DN, Seto WH, Lau YL (2004) Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995–2001. Emerg Infect Dis 10:1250–1257PubMed Ho PL, Que TL, Chiu SS, Yung RW, Ng TK, Tsang DN, Seto WH, Lau YL (2004) Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995–2001. Emerg Infect Dis 10:1250–1257PubMed
6.
Zurück zum Zitat Ho PL, Shek RH, Chow KH, Duan RS, Mak GC, Lai EL, Yam WC, Tsang KW, Lai WM (2005) Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000–2002. J Antimicrob Chemother 55:326–332CrossRefPubMed Ho PL, Shek RH, Chow KH, Duan RS, Mak GC, Lai EL, Yam WC, Tsang KW, Lai WM (2005) Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000–2002. J Antimicrob Chemother 55:326–332CrossRefPubMed
7.
Zurück zum Zitat Ho PL, Ho AY, Chow KH, Wong RC, Duan RS, Ho WL, Mak GC, Tsang KW, Yam WC, Yuen KY (2005) Occurrence and molecular analysis of extended-spectrum {beta}-lactamase-producing Proteus mirabilis in Hong Kong, 1999–2002. J Antimicrob Chemother. 55(6):840–845CrossRefPubMed Ho PL, Ho AY, Chow KH, Wong RC, Duan RS, Ho WL, Mak GC, Tsang KW, Yam WC, Yuen KY (2005) Occurrence and molecular analysis of extended-spectrum {beta}-lactamase-producing Proteus mirabilis in Hong Kong, 1999–2002. J Antimicrob Chemother. 55(6):840–845CrossRefPubMed
8.
Zurück zum Zitat Ho PL, Poon WW, Loke SL, Leung MS, Chow KH, Wong RC, Yip KS, Lai EL, Tsang KW, COMBAT study group (2007) Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women. J Antimicrob Chemother 60:140–144CrossRefPubMed Ho PL, Poon WW, Loke SL, Leung MS, Chow KH, Wong RC, Yip KS, Lai EL, Tsang KW, COMBAT study group (2007) Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women. J Antimicrob Chemother 60:140–144CrossRefPubMed
9.
Zurück zum Zitat Ling TK, Ying CM, Lee CC, Liu ZK (2005) Comparison of antimicrobial resistance of Acinetobacter baumannii clinical isolates from Shanghai and Hong Kong. Med Princ Pract 14:338–341CrossRefPubMed Ling TK, Ying CM, Lee CC, Liu ZK (2005) Comparison of antimicrobial resistance of Acinetobacter baumannii clinical isolates from Shanghai and Hong Kong. Med Princ Pract 14:338–341CrossRefPubMed
10.
Zurück zum Zitat Hirakata Y, Matsuda J, Miyazaki Y, Kamihira S, Kawakami S, Miyazawa Y, Ono Y, Nakazaki N, Hirata Y, Inoue M, Turnidge JD, Bell JM, Jones RN, Kohno S, SENTRY Asia-Pacific Participants (2005) Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998–2002). Diagn Microbiol Infect Dis 52:323–329CrossRefPubMed Hirakata Y, Matsuda J, Miyazaki Y, Kamihira S, Kawakami S, Miyazawa Y, Ono Y, Nakazaki N, Hirata Y, Inoue M, Turnidge JD, Bell JM, Jones RN, Kohno S, SENTRY Asia-Pacific Participants (2005) Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998–2002). Diagn Microbiol Infect Dis 52:323–329CrossRefPubMed
11.
Zurück zum Zitat Smith RD, Coast J (2002) Antimicrobial resistance: a global response. Bull World Health Organ 80:126–133PubMed Smith RD, Coast J (2002) Antimicrobial resistance: a global response. Bull World Health Organ 80:126–133PubMed
12.
Zurück zum Zitat Simonsen GS, Tapsall JW, Allegranzi B, Talbot EA, Lazzari S (2004) The antimicrobial resistance containment and surveillance approach—a public health tool. Bull World Health Organ 82:928–934PubMed Simonsen GS, Tapsall JW, Allegranzi B, Talbot EA, Lazzari S (2004) The antimicrobial resistance containment and surveillance approach—a public health tool. Bull World Health Organ 82:928–934PubMed
13.
Zurück zum Zitat Marr JJ, Moffet HL, Kunin CM (1988) Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis 157:869–876PubMed Marr JJ, Moffet HL, Kunin CM (1988) Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis 157:869–876PubMed
14.
Zurück zum Zitat Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE Jr, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C (1997) Society for healthcare epidemiology of America and infectious diseases society of america joint committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 25:584–599CrossRefPubMed Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE Jr, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C (1997) Society for healthcare epidemiology of America and infectious diseases society of america joint committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 25:584–599CrossRefPubMed
15.
Zurück zum Zitat Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM, Society for Healthcare Epidemiology of America, Infectious Diseases Society of America (2007) Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:159–177CrossRefPubMed Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM, Society for Healthcare Epidemiology of America, Infectious Diseases Society of America (2007) Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:159–177CrossRefPubMed
16.
Zurück zum Zitat Schentag JJ, Ballow CH, Fritz AL, Paladino JA, Williams JD, Cumbo TJ, Ali RV, Galletta VA, Gutfeld MB, Adelman MH (1993) Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory. Diagn Microbiol Infect Dis 16:255–264CrossRefPubMed Schentag JJ, Ballow CH, Fritz AL, Paladino JA, Williams JD, Cumbo TJ, Ali RV, Galletta VA, Gutfeld MB, Adelman MH (1993) Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory. Diagn Microbiol Infect Dis 16:255–264CrossRefPubMed
17.
Zurück zum Zitat Fraser GL, Stogsdill P, Dickens JD Jr, Wennberg DE, Smith RP Jr, Prato BS (1997) Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med 157:1689–1694CrossRefPubMed Fraser GL, Stogsdill P, Dickens JD Jr, Wennberg DE, Smith RP Jr, Prato BS (1997) Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med 157:1689–1694CrossRefPubMed
18.
Zurück zum Zitat Gums JG, Yancey RW Jr, Hamilton CA, Kubilis PS (1999) A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy 19:1369–1377CrossRefPubMed Gums JG, Yancey RW Jr, Hamilton CA, Kubilis PS (1999) A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy 19:1369–1377CrossRefPubMed
19.
Zurück zum Zitat Hamilton CD, Drew R, Janning SW, Latour JK, Hayward S (2000) Excessive use of vancomycin: a successful intervention strategy at an academic medical center. Infect Control Hosp Epidemiol 21:42–45CrossRefPubMed Hamilton CD, Drew R, Janning SW, Latour JK, Hayward S (2000) Excessive use of vancomycin: a successful intervention strategy at an academic medical center. Infect Control Hosp Epidemiol 21:42–45CrossRefPubMed
20.
Zurück zum Zitat Solomon DH, Van Houten L, Glynn RJ, Baden L, Curtis K, Schrager H, Avorn J (2001) Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med 161:1897–1902CrossRefPubMed Solomon DH, Van Houten L, Glynn RJ, Baden L, Curtis K, Schrager H, Avorn J (2001) Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med 161:1897–1902CrossRefPubMed
21.
Zurück zum Zitat Kumana CR, Ching TY, Kong Y, Ma EC, Kou M, Lee RA, Cheng VC, Chiu SS, Seto WH (2001) Curtailing unnecessary vancomycin usage in a hospital with high rates of methicillin resistant Staphylococcus aureus infections. Br J Clin Pharmacol 52:427–432CrossRefPubMed Kumana CR, Ching TY, Kong Y, Ma EC, Kou M, Lee RA, Cheng VC, Chiu SS, Seto WH (2001) Curtailing unnecessary vancomycin usage in a hospital with high rates of methicillin resistant Staphylococcus aureus infections. Br J Clin Pharmacol 52:427–432CrossRefPubMed
22.
Zurück zum Zitat Carling P, Fung T, Killion A, Terrin N, Barza M (2003) Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 24:699–706CrossRefPubMed Carling P, Fung T, Killion A, Terrin N, Barza M (2003) Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 24:699–706CrossRefPubMed
23.
Zurück zum Zitat Seto WH, Ching TY, Kou M, Chiang SC, Lauder IJ, Kumana CR (1996) Hospital antibiotic prescribing successfully modified by ‘immediate concurrent feedback’. Br J Clin Pharmacol 41:229–234CrossRefPubMed Seto WH, Ching TY, Kou M, Chiang SC, Lauder IJ, Kumana CR (1996) Hospital antibiotic prescribing successfully modified by ‘immediate concurrent feedback’. Br J Clin Pharmacol 41:229–234CrossRefPubMed
24.
Zurück zum Zitat Ho PL, Cheng JC, Ching PT, Kwan JK, Lim WW, Tong WC, Wu TC, Tse CW, Lam R, Yung R, Seto WH, Consensus Meeting Group on Antimicrobial Stewardship Programme (2006) Optimising antimicrobial prescription in hospitals by introducing an antimicrobial stewardship programme in Hong Kong: consensus statement. Hong Kong Med J 12:141–148PubMed Ho PL, Cheng JC, Ching PT, Kwan JK, Lim WW, Tong WC, Wu TC, Tse CW, Lam R, Yung R, Seto WH, Consensus Meeting Group on Antimicrobial Stewardship Programme (2006) Optimising antimicrobial prescription in hospitals by introducing an antimicrobial stewardship programme in Hong Kong: consensus statement. Hong Kong Med J 12:141–148PubMed
25.
Zurück zum Zitat Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, Citton R, D’Inzeo T, Fadda G, Cauda R, Spanu T (2007) Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 51:1987–1994CrossRefPubMed Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, Citton R, D’Inzeo T, Fadda G, Cauda R, Spanu T (2007) Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 51:1987–1994CrossRefPubMed
26.
Zurück zum Zitat Bru JP, Michallet M, Legrand C, Swierz P, Stahl JP, Leautet JB, Sotto JJ, Hollard D, Micoud M (1986) A prospective randomized study comparing the efficacy of Timentin alone or in combination with amikacin in the treatment of febrile neutropenic patients. J Antimicrob Chemother 17(Suppl C):203–209PubMed Bru JP, Michallet M, Legrand C, Swierz P, Stahl JP, Leautet JB, Sotto JJ, Hollard D, Micoud M (1986) A prospective randomized study comparing the efficacy of Timentin alone or in combination with amikacin in the treatment of febrile neutropenic patients. J Antimicrob Chemother 17(Suppl C):203–209PubMed
27.
Zurück zum Zitat Burke JP (1998) Antibiotic resistance—squeezing the balloon? JAMA 1998(280):1270–1271CrossRef Burke JP (1998) Antibiotic resistance—squeezing the balloon? JAMA 1998(280):1270–1271CrossRef
28.
Zurück zum Zitat Piroth L, Aubé H, Doise JM, Vincent-Martin M (1998) Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: are beta-lactamase inhibitors of therapeutic value? Clin Infect Dis 27:76–80CrossRefPubMed Piroth L, Aubé H, Doise JM, Vincent-Martin M (1998) Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: are beta-lactamase inhibitors of therapeutic value? Clin Infect Dis 27:76–80CrossRefPubMed
29.
Zurück zum Zitat Rice LB, Lakticová V, Helfand MS, Hutton-Thomas R (2004) In vitro antienterococcal activity explains associations between exposures to antimicrobial agents and risk of colonization by multiresistant enterococci. J Infect Dis 190:2162–2166CrossRefPubMed Rice LB, Lakticová V, Helfand MS, Hutton-Thomas R (2004) In vitro antienterococcal activity explains associations between exposures to antimicrobial agents and risk of colonization by multiresistant enterococci. J Infect Dis 190:2162–2166CrossRefPubMed
30.
Zurück zum Zitat Rice LB, Eckstein EC, DeVente J, Shlaes DM (1996) Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 23:118–124PubMed Rice LB, Eckstein EC, DeVente J, Shlaes DM (1996) Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 23:118–124PubMed
31.
Zurück zum Zitat Lan CK, Hsueh PR, Wong WW, Fung CP, Lau YT, Yeung JY, Young GT, Su CC (2003) Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase-producing organisms. J Microbiol Immunol Infect 36:182–186PubMed Lan CK, Hsueh PR, Wong WW, Fung CP, Lau YT, Yeung JY, Young GT, Su CC (2003) Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase-producing organisms. J Microbiol Immunol Infect 36:182–186PubMed
32.
Zurück zum Zitat Ho PL, Wong RC, Yip KS, Loke SL, Leung MS, Mak GC, Chow FK, Tsang KW, Que TL, COMBAT study group (2007) Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes. Diagn Microbiol Infect Dis 59:439–445CrossRefPubMed Ho PL, Wong RC, Yip KS, Loke SL, Leung MS, Mak GC, Chow FK, Tsang KW, Que TL, COMBAT study group (2007) Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes. Diagn Microbiol Infect Dis 59:439–445CrossRefPubMed
33.
Zurück zum Zitat Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, Mariano N, Marks S, Burns JM, Dominick D, Lim M (1998) Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280:1233–1237CrossRefPubMed Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, Mariano N, Marks S, Burns JM, Dominick D, Lim M (1998) Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280:1233–1237CrossRefPubMed
34.
Zurück zum Zitat Allegranzi B, Luzzati R, Luzzani A, Girardini F, Antozzi L, Raiteri R, Di Perri G, Concia E (2002) Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections. J Hosp Infect 52:136–140CrossRefPubMed Allegranzi B, Luzzati R, Luzzani A, Girardini F, Antozzi L, Raiteri R, Di Perri G, Concia E (2002) Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections. J Hosp Infect 52:136–140CrossRefPubMed
35.
Zurück zum Zitat Eagye KJ, Kuti JL, Nicolau DP (2009) Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol 30:746–752CrossRefPubMed Eagye KJ, Kuti JL, Nicolau DP (2009) Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol 30:746–752CrossRefPubMed
36.
Zurück zum Zitat Falagas ME, Kopterides P (2006) Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 64:7–15CrossRefPubMed Falagas ME, Kopterides P (2006) Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 64:7–15CrossRefPubMed
Metadaten
Titel
Antimicrobial stewardship program directed at broad-spectrum intravenous antibiotics prescription in a tertiary hospital
verfasst von
V. C. C. Cheng
K. K. W. To
I. W. S. Li
B. S. F. Tang
J. F. W. Chan
S. Kwan
R. Mak
J. Tai
P. Ching
P. L. Ho
W. H. Seto
Publikationsdatum
01.12.2009
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 12/2009
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-009-0803-8

Weitere Artikel der Ausgabe 12/2009

European Journal of Clinical Microbiology & Infectious Diseases 12/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.